"Photopheresis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A process in which peripheral blood is exposed in an extracorporeal flow system to photoactivated 8-methoxypsoralen (METHOXSALEN) and ultraviolet light - a procedure known as PUVA THERAPY. Photopheresis is at present a standard therapy for advanced cutaneous T-cell lymphoma; it shows promise in the treatment of autoimmune diseases.
| Descriptor ID |
D017893
|
| MeSH Number(s) |
E02.774.945.500.500 E04.292.762
|
| Concept/Terms |
Photopheresis- Photopheresis
- Extracorporeal Photopheresis
- Photopheresis, Extracorporeal
- Extracorporeal Photochemotherapy
- Extracorporeal Photochemotherapies
- Photochemotherapies, Extracorporeal
- Photochemotherapy, Extracorporeal
|
Below are MeSH descriptors whose meaning is more general than "Photopheresis".
Below are MeSH descriptors whose meaning is more specific than "Photopheresis".
This graph shows the total number of publications written about "Photopheresis" by people in this website by year, and whether "Photopheresis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2017 | 1 | 2 | 3 |
| 2018 | 4 | 1 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Photopheresis" by people in Profiles.
-
A case of psoriasis successfully treated by extracorporeal photopheresis during COVID-19 pandemic. Transfus Apher Sci. 2021 Oct; 60(5):103200.
-
Use of Ultraviolet Blood Irradiation Against Viral Infections. Clin Rev Allergy Immunol. 2021 Apr; 60(2):259-270.
-
United States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic. J Am Acad Dermatol. 2020 Aug; 83(2):703-704.
-
Pathogen-inactivated blood products for pediatric patients: blood safety, patient safety, or both? Transfusion. 2018 09; 58(9):2095-2101.
-
Extracorporeal Photopheresis: An Efficacious and Well-Tolerated Treatment for Cutaneous and Oral Mucosal Chronic Graft-versus-Host Disease. Dermatology. 2018; 234(1-2):23-30.
-
Photopheresis of a less than 10-kg child with acute graft versus host disease accompanied with hyperbilirubinemia: A case report. Transfus Apher Sci. 2018 Jun; 57(3):428-430.
-
Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome without Significantly Impacting Measured Pulmonary Functions. Biol Blood Marrow Transplant. 2018 09; 24(9):1906-1913.
-
Extracorporeal photopheresis as second-line treatment therapy in life-threatening primary graft dysfunction following lung transplantation. Pediatr Transplant. 2018 05; 22(3):e13145.
-
Analysis of long term CD4+CD25highCD127- T-reg cells kinetics in peripheral blood of lung transplant recipients. BMC Pulm Med. 2017 Jul 18; 17(1):102.
-
Mycobacterium genavense-induced spindle cell pseudotumor in a pediatric hematopoietic stem cell transplant recipient: Case report and review of the literature. Transpl Infect Dis. 2017 Apr; 19(2).